NanoSomiX Inc.
Blood test for early detection of Alzheimer’s disease
This article was originally published in Start Up
Executive Summary
Envision a simple blood test that can detect the presence of Alzheimer’s disease up to 10 years in advance of a standard clinical diagnosis. NanoSomiX Inc. is developing technology that evaluates brain-derived exosomes and reveals biological changes that are implicated in the pathogenesis of AD.